Evidence map›Paper›PMID 32195201›Full record

ArticleInternational journal of molecular and cellular medicine2019

Differentiation Potential of Nestin (+) and Nestin (-) Cells Derived from Human Bone Marrow Mesenchymal Stem Cells into Functional Insulin Producing Cells.

Sahar Rashed, Mahmoud Gabr, Abdel-Aziz Abdel-Aziz, Mahmoud Zakaria, Sherry Khater, Amani Ismail, Ali Fouad, Ayman Refaie

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular and cellular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sahar RashedDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Mahmoud GabrDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Abdel-Aziz Abdel-AzizBiochemistry Division, Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt.
Mahmoud ZakariaDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Sherry KhaterDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Amani IsmailDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Ali FouadDepartment of Biotechnology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Ayman RefaieNephrology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Mansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The feasibility of isolating and manipulating mesenchymal stem cells (MSCs) from human patients provides hope for curing numerous diseases and disorders. Recent phenotypic analysis has shown heterogeneity of MSCs. Nestin progenitor cell is a subpopulation within MSCs which plays a role in pancreas regeneration during embryogenesis. This study aimed to separate nestin

Indexed as

diabetes mellitusHuman bone marrow derived mesenchymal stem cellsinsulin producing cellsmesenchymal stem cellsreal time-quantitative PCR

Identifiers

PMID32195201
PMCPMC7073261
OpenAlexW3000492712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.